Breast cancer patients and caregiver inter- and intrapersonal spillover effects on anxiety, depression, pain, and fatigue during the first year of treatment.
설문조사
1/5 보강
ℹ️ 이 논문은 무료 전문이 아직 없습니다. 코퍼스 전체의 44.0%는 무료 가능 (통계 →) · 🏥 기관 EZproxy로 시도
[PURPOSE] Breast cancer patients and caregivers experience anxiety, depression, fatigue, and pain symptoms during treatment.
APA
Roberson PNE, Lenger KA, et al. (2026). Breast cancer patients and caregiver inter- and intrapersonal spillover effects on anxiety, depression, pain, and fatigue during the first year of treatment.. Journal of psychosocial oncology, 44(1), 1-24. https://doi.org/10.1080/07347332.2025.2501029
MLA
Roberson PNE, et al.. "Breast cancer patients and caregiver inter- and intrapersonal spillover effects on anxiety, depression, pain, and fatigue during the first year of treatment.." Journal of psychosocial oncology, vol. 44, no. 1, 2026, pp. 1-24.
PMID
40435506 ↗
Abstract 한글 요약
[PURPOSE] Breast cancer patients and caregivers experience anxiety, depression, fatigue, and pain symptoms during treatment. The present study sought to determine which times during the first year of breast cancer treatment have the greatest risk of interpersonal spillover on patient and caregiver symptoms.
[METHODS] Self-report survey data were collected from 55 estrogen-receptor positive (ER+) stage I-III breast cancer patients and their identified caregivers throughout the first year of primary treatment (e.g., surgery, radiation) to assess symptoms of biobehavioral reactivity (i.e., anxiety, depression, fatigue, and pain). Surveys from patients and caregivers were provided at baseline (before treatment), 6 weeks after surgery, 6 months after surgery, and 12 months after surgery. The present sample comprised primarily white, middle-income individuals with an average age of 63 years old. Data were analyzed using longitudinal Actor-Partner Interdependence Modeling in Mplus.
[RESULTS] Intrapersonally, preceding symptoms predicted poor future functioning for both patients and caregivers across the majority of time points. Interpersonally, patients' anxiety at 6 weeks ( = .04) and fatigue at baseline ( = .01) and 6 months ( = .04) predicted greater caregiver symptoms at the subsequent clinically relevant times. However, concurrent spillover occurs for all of the measures of biobehavioral reactivity at one or more times during treatment.
[CONCLUSION] Anxiety and fatigue are vulnerable to longitudinal interpersonal "spillover" of symptoms, particularly for caregivers, starting early in treatment. We also find in this pilot study that concurrent biobehavioral reactivity symptom spillover occurs in some form throughout the first year of breast cancer treatment. It is common for interventions that target symptoms of biobehavioral reactivity to focus on the individual patient. However, given the degree of longitudinal and concurrent spillover observed between breast cancer patients and caregivers, we recommend future research test behavioral interventions that teach dyadic coping skills in addition to replicating findings with a fully powered prospective study.
[METHODS] Self-report survey data were collected from 55 estrogen-receptor positive (ER+) stage I-III breast cancer patients and their identified caregivers throughout the first year of primary treatment (e.g., surgery, radiation) to assess symptoms of biobehavioral reactivity (i.e., anxiety, depression, fatigue, and pain). Surveys from patients and caregivers were provided at baseline (before treatment), 6 weeks after surgery, 6 months after surgery, and 12 months after surgery. The present sample comprised primarily white, middle-income individuals with an average age of 63 years old. Data were analyzed using longitudinal Actor-Partner Interdependence Modeling in Mplus.
[RESULTS] Intrapersonally, preceding symptoms predicted poor future functioning for both patients and caregivers across the majority of time points. Interpersonally, patients' anxiety at 6 weeks ( = .04) and fatigue at baseline ( = .01) and 6 months ( = .04) predicted greater caregiver symptoms at the subsequent clinically relevant times. However, concurrent spillover occurs for all of the measures of biobehavioral reactivity at one or more times during treatment.
[CONCLUSION] Anxiety and fatigue are vulnerable to longitudinal interpersonal "spillover" of symptoms, particularly for caregivers, starting early in treatment. We also find in this pilot study that concurrent biobehavioral reactivity symptom spillover occurs in some form throughout the first year of breast cancer treatment. It is common for interventions that target symptoms of biobehavioral reactivity to focus on the individual patient. However, given the degree of longitudinal and concurrent spillover observed between breast cancer patients and caregivers, we recommend future research test behavioral interventions that teach dyadic coping skills in addition to replicating findings with a fully powered prospective study.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.